0000000000277115

AUTHOR

Jordi Llop

0000-0002-0821-9838

showing 5 related works from this author

Restricted rotation in unbridged sandwich complexes: rotational behavior of closo-[Co(eta 5-NC4H4)(C2B9H11)] derivatives.

2005

Rotation about the centroid/ metal/centroid axis in ferrocene is facile; the activation energy is 1-5 kcal mol - 1 . The structurally similar sandwich complexes derived from closo-[3-Co(η 5 -NC 4 H 4 )-1,2-C 2 B 9 H 1 1 ] (1) have a different rotational habit. In 1, the cis rotamer in which the pyrrolyl nitrogen atom bisects the carboranyl cluster atoms is 3.5 kcal mol - 1 more stable in energy than the rotamer that is second lowest in energy. This cis rotamer is wide, spanning 216°, and may be split into three rotamers of almost equal energy by substituting the N and the carboranyl carbon atoms adequately. To support this statement, closo-[3-Co(η 5 -NC 4 H 4 )-1,2-(CH 3 ) 2 -1,2-C 2 B 9 H …

chemistry.chemical_classificationSteric effects010405 organic chemistryStereochemistryOrganic ChemistryHeteroatomGeneral Chemistry010402 general chemistry7. Clean energy01 natural sciencesCatalysis0104 chemical sciencesRotational energyIonElectronegativitychemistry.chemical_compoundCrystallographychemistryFerroceneCounterionConformational isomerismChemistry (Weinheim an der Bergstrasse, Germany)
researchProduct

124I Radiolabeling of a AuIII‐NHC Complex for In Vivo Biodistribution Studies†

2020

Abstract AuIII complexes with N‐heterocyclic carbene (NHC) ligands have shown remarkable potential as anticancer agents, yet their fate in vivo has not been thoroughly examined and understood. Reported herein is the synthesis of new AuIII‐NHC complexes by direct oxidation with radioactive [124I]I2 as a valuable strategy to monitor the in vivo biodistribution of this class of compounds using positron emission tomography (PET). While in vitro analyses provide direct evidence for the importance of AuIII‐to‐AuI reduction to achieve full anticancer activity, in vivo studies reveal that a fraction of the AuIII‐NHC prodrug is not immediately reduced after administration but able to reach the major…

Imaging Agents | Hot Paperpositron emission tomography010405 organic chemistryChemistryGeneral ChemistryProdrug010402 general chemistryanticancer01 natural sciencesCombinatorial chemistryCatalysisIn vitro3. Good health0104 chemical sciencesIn vivoIn vivo biodistributionSettore CHIM/03 - Chimica Generale E InorganicametallodrugsN-heterocyclic carbenesanticancer; metallodrugs; N-heterocyclic carbenes; positron emission tomography; radiochemistryradiochemistryResearch ArticlesResearch ArticleAngewandte Chemie (International Ed. in English)
researchProduct

The [3,3′-Co(1,2-C2B9H11)2]– anion as a platform for new materials: synthesis of its functionalized monosubstituted derivatives incorporating synthon…

2003

[3,3′-Co(8-C5H10O-1,2-C2B9H10)(1′,2′-C2B9H11)] (2) was synthesized by reaction of the caesium salt of [Co(C2B9H11)2]− with dimethyl sulfate in the presence of sulfuric acid as catalyst and tetrahydropyrane as solvent; the zwitterionic compound (2) yielded [3,3′-Co(8-C4H4N-(CH2)5-O-1,2-C2B9H10)(1′,2′-C2B9H11)]− (6), [3,3′-Co(8-C8H6N-(CH2)5-O-1,2-C2B9H10)(1′,2′-C2B9H11)]− (7), and [3,3′-Co(8-C12H8N-(CH2)5-O-1,2-C2B9H10)(1′,2′-C2B9H11)]− (8) through the nucleophilic addition of potassium pyrrolyl, indolyl and carbazolyl, respectively. The nucleophilic addition of the same salts on [3,3′-Co(8-C4H8O2-1,2-C2B9H10)(1′,2′-C2B9H11)] (1) yielded, respectively, [3,3′-Co(8-C4H4N-(CH2)2-O-(CH2)2-O-1,2-C…

chemistry.chemical_classificationNucleophilic additionStereochemistryChemistrySynthonSalt (chemistry)Medicinal chemistryInorganic ChemistrySolventDimethyl sulfatechemistry.chemical_compoundNucleophileIntramolecular forceMoleculeDalton Transactions
researchProduct

CCDC 1989307: Experimental Crystal Structure Determination

2021

Related Article: Federica Guarra, Alessio Terenzi, Christine Pirker, Rossana Passannante, Dina Baier, Ennio Zangrando, Vanessa G��mez���Vallejo, Tarita Biver, Chiara Gabbiani, Walter Berger, Jordi Llop, Luca Salassa|2020|Angew.Chem.,Int.Ed.|59|17130|doi:10.1002/anie.202008046

Space GroupCrystallographyCrystal SystemCrystal Structure(1-butyl-3-methyl-23-dihydro-1H-imidazol-2-yl)-(chloro)-diiodo-gold(iii)Cell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1989306: Experimental Crystal Structure Determination

2021

Related Article: Federica Guarra, Alessio Terenzi, Christine Pirker, Rossana Passannante, Dina Baier, Ennio Zangrando, Vanessa G��mez���Vallejo, Tarita Biver, Chiara Gabbiani, Walter Berger, Jordi Llop, Luca Salassa|2020|Angew.Chem.,Int.Ed.|59|17130|doi:10.1002/anie.202008046

Space GroupCrystallographyCrystal Systembis(1-butyl-3-methyl-23-dihydro-1H-imidazol-2-ylidene)-(diiodo)-gold(iii) hexafluorophosphateCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct